Article Versions Notes

Perrone E, Ghai K, Eismant A, Andreassen M, Langer SW, Knigge U, Kjaer A, Baum RP. Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu/²²⁵AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas. Diagnostics. 2024; 14(9):907. https://doi.org/10.3390/diagnostics14090907

Perrone, Elisabetta, Kriti Ghai, Aleksandr Eismant, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge, Andreas Kjaer, and Richard P. Baum. 2024. "Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu/²²⁵AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas" Diagnostics 14, no. 9: 907. https://doi.org/10.3390/diagnostics14090907

Perrone, E., Ghai, K., Eismant, A., Andreassen, M., Langer, S. W., Knigge, U., Kjaer, A., & Baum, R. P. (2024). Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu/²²⁵AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas. Diagnostics, 14(9), 907. https://doi.org/10.3390/diagnostics14090907